Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BPT
13801
PUT
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $5.77K | ﹤0.01% |
10,600
+2,300
| +28% | +$2.32K |
2024 Q3
1 quarter
|
|
13802
CALL
BGSF Inc
BGSF
$53.3M
| $5.76K | ﹤0.01% |
1,100
-400
| -27% | -$2.76K |
2024 Q2
2 quarters
|
|
|
THR
13803
CALL
DELISTED
Thermon Group Holdings
THR
| $5.75K | ﹤0.01% |
+200
| New | +$5.89K |
2024 Q4
0 quarters
|
|
|
SVIIR
13804
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
| $5.73K | ﹤0.01% |
+81,500
| New | +$5.44K |
2024 Q4
0 quarters
|
|
13805
PUT
NRX Pharmaceuticals
NRXP
$123M
| $5.72K | ﹤0.01% |
2,600
+1,600
| +160% | +$2.15K |
2021 Q3
13 quarters
|
|
13806
CALL
TherapeuticsMD
TXMD
$24M
| $5.68K | ﹤0.01% |
6,600
+2,100
| +47% | +$2.96K |
2022 Q3
9 quarters
|
|
13807
CALL
Banco Santander Chile
BSAC
$15.4B
| $5.66K | ﹤0.01% |
300
-500
| -63% | -$9.77K |
2024 Q3
1 quarter
|
|
13808
PUT
Health Catalyst
HCAT
$132M
| $5.66K | ﹤0.01% |
800
-5,600
| -88% | -$44.6K |
2022 Q3
9 quarters
|
|
|
TBPH
13809
CALL
DELISTED
Theravance Biopharma
TBPH
| $5.65K | ﹤0.01% |
600
+400
| +200% | +$3.64K |
2021 Q3
13 quarters
|
|
|
HOOK
13810
PUT
DELISTED
HOOKIPA Pharma
HOOK
| $5.63K | ﹤0.01% |
2,800
+1,520
| +119% | +$4.7K |
2024 Q1
3 quarters
|
|
13811
PUT
Finance of America Companies
FOA
$123M
| $5.62K | ﹤0.01% |
+200
| New | +$3.56K |
2024 Q4
0 quarters
|
|
13812
CALL
Focus Universal
FCUV
$3.12M
| $5.6K | ﹤0.01% |
40
+13
| +48% | +$1.33K |
2024 Q3
1 quarter
|
|
13813
PUT
Greenlight Captial
GLRE
$481M
| $5.6K | ﹤0.01% |
400
| – | – |
2023 Q4
4 quarters
|
|
|
PHX
13814
PUT
DELISTED
PHX Minerals
PHX
| $5.6K | ﹤0.01% |
1,400
-30,600
| -96% | -$112K |
2024 Q2
2 quarters
|
|
|
CLLS
13815
CALL
Cellectis
CLLS
$145M
| $5.58K | ﹤0.01% |
3,100
-2,800
| -47% | -$5.22K |
2024 Q2
2 quarters
|
|
13816
PUT
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.4B
| $5.58K | ﹤0.01% |
200
-600
| -75% | -$17K |
2024 Q3
1 quarter
|
|
13817
PUT
Brixmor Property Group
BRX
$8.36B
| $5.57K | ﹤0.01% |
200
| – | – |
2022 Q4
8 quarters
|
|
13818
ProShares Ultra Real Estate
URE
$46.6M
| $5.56K | ﹤0.01% |
89
-3,278
| -97% | -$232K |
2023 Q3
5 quarters
|
|
13819
CALL
JPMorgan BetaBuilders Europe ETF
BBEU
$8.86B
| $5.54K | ﹤0.01% |
+100
| New | +$5.86K |
2024 Q4
0 quarters
|
|
|
MPX
13820
PUT
DELISTED
Marine Products Corp
MPX
| $5.5K | ﹤0.01% |
600
-2,000
| -77% | -$19.2K |
2022 Q4
8 quarters
|
|
13821
iShares MSCI Europe Financials ETF
EUFN
$3.87B
| $5.5K | ﹤0.01% |
+236
| New | +$5.65K |
2024 Q4
0 quarters
|
|
|
STKH
13822
CALL
Steakholder Foods
STKH
$734K
| $5.47K | ﹤0.01% |
27
-8
| -23% | -$2.31K |
2024 Q3
1 quarter
|
|
13823
PUT
Financial Institutions
FISI
$779M
| $5.46K | ﹤0.01% |
200
-100
| -33% | -$2.63K |
2022 Q4
8 quarters
|
|
|
NXDR
13824
PUT
Nextdoor Holdings
NXDR
$959M
| $5.45K | ﹤0.01% |
2,300
-9,200
| -80% | -$22.8K |
2021 Q3
13 quarters
|
|
13825
CALL
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$598M
| $5.45K | ﹤0.01% |
+100
| New | +$5.64K |
2024 Q4
0 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.